MGRX
Mangoceuticals, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$0.41
+5.30%Year over year
Reported trailing growth
- Revenue
- -38.9%
- EBITDA
- -10.4%
- EBIT
- +2.7%
- EPS
- +63.8%
- Free cash flow
- +33.2%
- Operating cash flow
- +33.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +270.9%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- +50.7%
- Free cash flow
- -20.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026